Logo image of NVVE

NUVVE HOLDING CORP (NVVE) Stock Fundamental Analysis

NASDAQ:NVVE - Nasdaq - US67079Y3080 - Common Stock - Currency: USD

1.67  +0.02 (+1.21%)

Premarket: 1.66 -0.01 (-0.6%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NVVE. NVVE was compared to 92 industry peers in the Electrical Equipment industry. NVVE has a bad profitability rating. Also its financial health evaluation is rather negative. NVVE is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year NVVE has reported negative net income.
NVVE had a negative operating cash flow in the past year.
In the past 5 years NVVE always reported negative net income.
NVVE had a negative operating cash flow in each of the past 5 years.
NVVE Yearly Net Income VS EBIT VS OCF VS FCFNVVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -146.93%, NVVE is doing worse than 86.96% of the companies in the same industry.
NVVE has a Return On Equity of -335.00%. This is in the lower half of the industry: NVVE underperforms 73.91% of its industry peers.
Industry RankSector Rank
ROA -146.93%
ROE -335%
ROIC N/A
ROA(3y)-117.31%
ROA(5y)-98.29%
ROE(3y)-191.9%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NVVE Yearly ROA, ROE, ROICNVVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 200 -200 400

1.3 Margins

The Gross Margin of NVVE (21.18%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of NVVE has declined.
NVVE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.02%
GM growth 5Y-29.63%
NVVE Yearly Profit, Operating, Gross MarginsNVVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

2

2. Health

2.1 Basic Checks

NVVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
NVVE has less shares outstanding than it did 1 year ago.
The number of shares outstanding for NVVE has been reduced compared to 5 years ago.
Compared to 1 year ago, NVVE has a worse debt to assets ratio.
NVVE Yearly Shares OutstandingNVVE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 200K 400K 600K
NVVE Yearly Total Debt VS Total AssetsNVVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -16.55, we must say that NVVE is in the distress zone and has some risk of bankruptcy.
NVVE has a worse Altman-Z score (-16.55) than 89.13% of its industry peers.
NVVE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
NVVE has a Debt to Equity ratio of 0.00. This is in the better half of the industry: NVVE outperforms 79.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -16.55
ROIC/WACCN/A
WACC8.92%
NVVE Yearly LT Debt VS Equity VS FCFNVVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

A Current Ratio of 1.30 indicates that NVVE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.30, NVVE is doing worse than 70.65% of the companies in the same industry.
NVVE has a Quick Ratio of 1.30. This is a bad value and indicates that NVVE is not financially healthy enough and could expect problems in meeting its short term obligations.
NVVE has a worse Quick ratio (0.60) than 80.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.6
NVVE Yearly Current Assets VS Current LiabilitesNVVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

7

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.94% over the past year.
Looking at the last year, NVVE shows a very strong growth in Revenue. The Revenue has grown by 28.22%.
NVVE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.73% yearly.
EPS 1Y (TTM)6.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.71%
Revenue 1Y (TTM)28.22%
Revenue growth 3Y27.73%
Revenue growth 5YN/A
Sales Q2Q%-29.2%

3.2 Future

Based on estimates for the next years, NVVE will show a very strong growth in Earnings Per Share. The EPS will grow by 25.91% on average per year.
Based on estimates for the next years, NVVE will show a very strong growth in Revenue. The Revenue will grow by 118.86% on average per year.
EPS Next Y93.54%
EPS Next 2Y40.55%
EPS Next 3Y25.91%
EPS Next 5YN/A
Revenue Next Year81.41%
Revenue Next 2Y123.73%
Revenue Next 3Y118.86%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NVVE Yearly Revenue VS EstimatesNVVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
NVVE Yearly EPS VS EstimatesNVVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -500 -1K -1.5K

1

4. Valuation

4.1 Price/Earnings Ratio

NVVE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NVVE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVVE Price Earnings VS Forward Price EarningsNVVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NVVE Per share dataNVVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600

4.3 Compensation for Growth

A more expensive valuation may be justified as NVVE's earnings are expected to grow with 25.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.55%
EPS Next 3Y25.91%

0

5. Dividend

5.1 Amount

NVVE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NUVVE HOLDING CORP

NASDAQ:NVVE (3/7/2025, 8:00:02 PM)

Premarket: 1.66 -0.01 (-0.6%)

1.67

+0.02 (+1.21%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)03-26 2025-03-26/amc
Inst Owners12.53%
Inst Owner Change-99.97%
Ins Owners2.04%
Ins Owner Change0.5%
Market Cap2.15M
Analysts82.86
Price TargetN/A
Short Float %7.82%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-981.55%
Min EPS beat(2)-1406.24%
Max EPS beat(2)-556.86%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-83.65%
Min Revenue beat(2)-85.4%
Max Revenue beat(2)-81.89%
Revenue beat(4)1
Avg Revenue beat(4)-43.4%
Min Revenue beat(4)-85.4%
Max Revenue beat(4)39.94%
Revenue beat(8)4
Avg Revenue beat(8)-10.34%
Revenue beat(12)4
Avg Revenue beat(12)-28.07%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 0.27
P/tB 0.31
EV/EBITDA N/A
EPS(TTM)-644
EYN/A
EPS(NY)-15.91
Fwd EYN/A
FCF(TTM)-16.34
FCFYN/A
OCF(TTM)-16.23
OCFYN/A
SpS4.6
BVpS6.3
TBVpS5.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -146.93%
ROE -335%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.18%
FCFM N/A
ROA(3y)-117.31%
ROA(5y)-98.29%
ROE(3y)-191.9%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.02%
GM growth 5Y-29.63%
F-Score3
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.33%
Cap/Sales 2.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.6
Altman-Z -16.55
F-Score3
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)120.61%
Cap/Depr(5y)76.73%
Cap/Sales(3y)5.64%
Cap/Sales(5y)3.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.71%
EPS Next Y93.54%
EPS Next 2Y40.55%
EPS Next 3Y25.91%
EPS Next 5YN/A
Revenue 1Y (TTM)28.22%
Revenue growth 3Y27.73%
Revenue growth 5YN/A
Sales Q2Q%-29.2%
Revenue Next Year81.41%
Revenue Next 2Y123.73%
Revenue Next 3Y118.86%
Revenue Next 5YN/A
EBIT growth 1Y13.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year30.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.5%
OCF growth 3YN/A
OCF growth 5YN/A